Pharmafile Logo
Pharmafocus logo
Advanced Search

Oxford

Showing 15 posts of 16 posts found.

Oxford University to collaborate with Oracle on COVID variant research

May 17, 2021
Sales and Marketing AI, COVID-19, Oxford, variants

In response to emerging variants of COVID-19, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS), combining …

News
psm_v46_d168_mesial_view_of_the_human_brain

Rising to the challenge of delivering therapeutic discovery for mental disorders

November 15, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health

Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …

Feature
uk

UK to push earlier diagnosis and better treatment with 5 AI-driven technology centres

November 6, 2018
Manufacturing and Production, Research and Development AI, Leeds, London, Oxford, UK, glasgow, pharma

The UK’s Business Secretary has announced the introduction of five specialist collaborative centres across the UK which with leverage advanced …

News
artificial-intelligence-2228610_640

New AI system for lung cancer and heart disease could save NHS billions

January 4, 2018
Research and Development, Sales and Marketing Optellum, Oxford, Sir John Bell, heart disease, lung cancer, pharma

A team of researchers at Oxford’s John Radcliffe Hospital have unveiled a new artificial intelligence system which they claim could …

News
New planned building for genomics firm Illumina in Cambridge image

UK pharma’s ‘Golden Triangle’ faces competition from new challengers

June 29, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BioGateway, Cambridge, London, Oxford

The UK’s medical and scientific base is regarded as one of the world’s best.

Feature
Google image

Google backs Oxford Sciences Innovation

June 22, 2015
Medical Communications, Sales and Marketing Oxford, Oxford Sciences Innovation, google, ventures

Google has invested into a company that funds spinoffs from Oxford University’s technology and science departments called Oxford Sciences Innovation …

News
Vaccine image

New malaria vaccine found effective in adults

May 8, 2015
Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria

A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …

News
MedImmune image

AstraZeneca signs immuno-oncology deal with UK firm

April 16, 2015
Research and Development, Sales and Marketing AstraZeneca, IMCgp100, MEDI4736, MedImmune, Oxford, immuno-oncology, immunocore, melanoma, tremelimumab

UK pharma and biotech firms AstraZeneca and Immunocore are teaming up to launch early-stage studies of potential new cancer treatments. …

News
Alzheimer’s Research UK image

£30m drug discovery centres launched to overcome pharma ‘funding fatigue’

February 18, 2015
Research and Development, Sales and Marketing Alzheimer’s Research UK, Cambridge, London, Oxford, dementia, funding, pharma

Three new drug discovery institutes will be launched in the UK with a £30 million commitment to fast-track the development …

News
Pills image

Hormone replacement therapy elevates ovarian cancer risk

February 13, 2015
Research and Development, Sales and Marketing Cancer, HRT, Lancet, Oxford, oncology, ovarian

According to a new study women who undergo hormone replacement therapy nearly double their risk of developing ovarian cancer.  Findings …

News
Asthma image

Laser testing could lead to improved asthma therapies

November 13, 2014
Research and Development, Sales and Marketing Oxford, asthma, pmdis, pope, stfc

UK scientists have used a laser beam trap to examine how drug particles from asthma inhalers travel through the air …

News
Lilly image

Lilly signs Immunocore deal

July 17, 2014
Research and Development, Sales and Marketing Cancer, Oxford, biotech, immunocore, lilly

Eli Lilly has signed a deal with one of the UK’s most high-profile biotech firms to research and potentially develop …

News

Bayer in Oxford tie-up

July 11, 2014
Research and Development, Sales and Marketing Bayer, Oxford, endometriosis, university

Bayer HealthCare and the UK’s University of Oxford have signed an agreement to look for new treatments for two common …

News
Aerial view of Milton Park image

UK invests in Oxford bioscience site

January 31, 2014
Research and Development, Sales and Marketing Milton Park, Oxford, UK, bioscience, government

The government is putting £7 million into Milton Park, near Oxford, to boost the building of a new laboratory and …

News

Billions spent on European cancer care

October 15, 2013
Research and Development, Sales and Marketing Cancer, Europe, Lancet, Oxford, Pfizer

A new report has shown that cancer cost the European Union a total of €126 billion in 2009, with healthcare …

News

Latest content

Prism BioLab and Ono Pharmaceutical enter joint research and licensing agreement

April 25, 2024

Ascendis Pharma’s Yorvipath approved by MHRA for hypoparathyroidism treatment

April 25, 2024

Eli Lilly acquires new manufacturing facility from Nexus Pharmaceuticals

April 24, 2024

GSK’s Jemperli accepted for FDA review for endometrial cancer treatment

April 24, 2024

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024